Antiprotozoal activity of ferroquine

Parasitology Research

Volumn 112, Issue 2, 2013, Pages 665-669

  Pomel, S ^a   Biot, C ^b   Bories, C ^a   Loiseau, P M ^a  

^a UNIVERSITÉ PARIS SACLAY   (France)

^b UNIV LILLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FERROQUINE; PENTAMIDINE;

AFRICAN TRYPANOSOMIASIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIPROTOZOAL ACTIVITY; ARTICLE; BLOODSTREAM INFECTION; CONTROLLED STUDY; DRUG EFFICACY; DRUG MEGADOSE; DRUG STRUCTURE; IN VITRO STUDY; IN VIVO STUDY; LEISHMANIA; MAXIMUM TOLERATED DOSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRICHOMONAS VAGINALIS; TRYPANOSOMA; TRYPANOSOMA BRUCEI;

AMINOQUINOLINES; ANIMALS; ANTIPROTOZOAL AGENTS; FERROUS COMPOUNDS; LEISHMANIA; MICE; PARASITIC SENSITIVITY TESTS; TREATMENT OUTCOME; TRICHOMONAS VAGINALIS; TRYPANOSOMA; TRYPANOSOMIASIS, AFRICAN;

MUS; PROTISTA; TRICHOMONAS VAGINALIS; TRYPANOSOMA; TRYPANOSOMA BRUCEI BRUCEI; TRYPANOSOMA BRUCEI GAMBIENSE;

EID: 84878346058     PISSN: 09320113     EISSN: 14321955     Source Type: Journal    
DOI: 10.1007/s00436-012-3183-4     Document Type: Article

References (24)

1. Alvar J, Velez ID, Bern C, Herrero M, Desjeux P, Cano J, Jannin J, den Boer M, the WHO Leishmaniasis Control Team (2011) Leishmaniasis worlwide and global estimates of its incidence. PLoS One 7:e35671
2. Baneth G, Koutinas AF, Solano-Gallego L, Bourdeau P, Ferrer L (2008) Canine leishmaniosis - new concepts and insights on an expanding zoonosis: part one. Trends Parasitol 24:324-330
3. Biot C, TaramelliD F-BI, Maciejewski LA, Boyce M, Nowogrocki G, Brocard JS, Basilico N, Olliaro P, Egan TJ (2005) Insights into the mechanism of action of ferroquine. Relationship between physicochemical properties and antiplasmodial activity. Mol Pharm 2:185-193
4. Bourjot M, Apel C, Martin MT, Grellier P, Nguyen VH, Guéritte H, Litaudon M (2010) Antiplasmodial, antitrypanosomal, and cytotoxic activities of prenylated flavonoids isolated from the stem bark of Artocarpus sytracifolius. Planta Med 76:1600-1604
5. Camuzat-Dedenis B, Provot O, Cointeaux L, Perroux V, Berrien JF, Bories C, Loiseau PM, Mayrargue J (2001) Synthesis and in vitro trichomonacidal activities of some new dialkylperoxides and 1,2,4-trioxanes. Eur J Med Chem 36:837-842
6. Chavain N, Vezin H, Dive D, Touati N, Paul JF, Buisine E, Biot C (2008) Investigation of the redox behavior of ferroquine, a new antimalarial. Mol Pharm 5:710-716
7. Dubar F, Khalife J, Brocard J, Dive D, Biot C (2008) Ferroquine, an ingenious antimalarial drug: thoughts on the mechanism of action. Molecules 13:2900-2907
8. Dubar F, Egan TJ, Pradines B, Kuter D, Ncokazi KK, Forge D, Paul JF, Pierrot C, Kalamou H, Khalife J, Buisine E, Rogier C, Vezin H, Forfar I, Slomianny C, Trivelli X, Kapishnikov S, Leiserowitz L, Dive D, Biot C (2011) The antimalarial ferroquine: role of the metal and intramolecular hydrogen bond in activity and resistance. ACS Chem Biol 6:275-287
9. Dubar F, Bohic S, Dive D, Guérardel Y, Cloetens P, Khalife J, Biot C (2012a) Deciphering the resistance-counteracting functions of ferroquine in Plasmodium falciparum-infected erythrocytes. ACS Med Chem Lett 3:480-483
10. Dubar F, Bohic S, Slomianny C, Morin JC, Thomas P, Kalamou H, Guérardel Y, Cloetens P, Khalife J, Biot C (2012b) In situ nanochemical imaging of label-free drugs: a case study of antimalarials in Plasmodium falciparum-infected erythrocytes. Chem Commun (Camb) 48:910-912
11. Frézard F, Demicheli C, Ribeiro RR (2009) Pentavalent antimonials: new perspectives for old drugs. Molecules 14:2317-2346
12. Henry M, Briolant S, Fontaine A, Mosnier J, Baret E, Amalvict R, Fusaï T, Fraisse L, Rogier C, Pradines B (2008) In vitro activity of ferroquine is independent of polymorphisms in transport protein genes implicated in quinoline resistance in Plasmodium falciparum. Antimicrob Agents Chemother 52:2755-2759
13. Kirkcaldy RD, Augostini P, Asbel LE, Bernstein KT, Kerani RP, Mettenbrink CJ, Pathela P, Schwebke JR, Secor WE, Workowski KA, Davis D, Braxton J, Weinstock HS (2012) Trichomonas vaginalis antimicrobial drug resistance in 6 US cities, STD surveillance network, 2009-2010. Emerg Infect Dis 18:939-943
14. Loiseau PM, Craciunescu DG, Doadrio-Villarejo JC, Certad-Fombona G, Gayral P (1992) Pharmacomodulations of new organometallic complexes Ir, Pt, Rh, Pd, Os: in vitro and in vivo trypanocidal study aginst Trypanosoma brucei brucei. Trop Med Parasitol 43:110-114
15. Loiseau PM, Lubert P, Wolf JG (2000) Contribution of dithiol ligands to in vitro and in vivo trypanocidal activities of dithiaarsanes and investigation of ligand exchange in an aqueous solution. Antimicrob Agents Chemother 44:2954-2961
16. Loiseau PM, Gutierrez-Rios MT, De Frutos MI, Craciunescu DG (2001) Structure-activity relationships of new organometallic complexes active against bloodstream form of Trypanosoma brucei brucei. Parasitol Res 87:566-569
17. Martinez-Grueiro M, Gimenez-Pardo C, Gomez-Barrio A, Franck X, Fournet A, Hocquemiller R, Figadère B, Casado-Escribano N (2005) Nematocidal and trichomonacidal activities of 2-substitued quinolines. Farmaco 60:219-224
18. Mbongo N, Loiseau PM, Lawrence F, Bories C, Craciunescu DG, Robert-Gero M (1997) In vitro sensitivity of Leishmania donovani to organometallic derivatives of pentamidine. Parasitol Res 83:515-517
19. Mombo-Ngoma G, Supan C, Dal-Bianco MP, Missinou MA, Matsiegui PB, Ospina-Salazar CL, Issifou S, Ter-Minassian D, Ramharter M, Kombila M, Kremsner PG, Lell B (2011) Phase I randomized dose-ascending placebo controlled trials of ferroquine - a candidate anti-malarial drug - in adults with asymptomatic Plasmodium falciparum infection. Malar J 10:53
20. Nok AJ (2003) Arsenicals (melarsoprol), pentamidine and suramin in the treatment of human African trypanosomiasis. Parasitol Res 90:71-79
21. Peyron C, Benhida R, Bories C, Loiseau PM (2005) Synthesis and in vitro antileishmanial activity of 5-substituted-2′-deoxyuridine derivatives. Bioorg Chem 33:439-447
22. Simarro PP, Diarra A, Ruiz-Postigo JA, Franco JR, Jannin JG (2011) The human african trypanosomiasis control and surveillance programme of the World Health Organization 2000-2009: the way forward. PLoS Negl Trop Dis 5:e1007
23. Supan C, Mombo-Ngoma G, Dal-Bianco MP, Ospina-Salazar CL, Issifou S, Mazuir F, Filali-Ansary A, Biot C, Ter-Minassian D, Ramharter M, Kremsner PG, Lell B (2012) Pharmacokinetics of ferroquine, a novel 4-amino-quinoline, in asymptomatic Plasmodium falciparum infections. Actimicrob Agents Chemother 56:3165-3173
24. WHO (2012) Human African Trypanosomiasis (sleeping sickness) fact sheet, vol 259. WHO, Geneva